362 related articles for article (PubMed ID: 34372775)
1. Prevalence of sero-markers and non-invasive assessment of liver cirrhosis in patients with Hepatitis B virus infection in Freetown, Sierra Leone: a cross-sectional study.
Lakoh S; Firima E; Jiba DF; Kamara MN; Gashau W; Deen GF; Adekanmbi O; Yendewa GA
BMC Gastroenterol; 2021 Aug; 21(1):320. PubMed ID: 34372775
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and associated knowledge of hepatitis B infection among healthcare workers in Freetown, Sierra Leone.
Qin YL; Li B; Zhou YS; Zhang X; Li L; Song B; Liu P; Yuan Y; Zhao ZP; Jiao J; Li J; Sun Y; Sevalie S; Kanu JE; Song YJ; Jiang JF; Sahr F; Jiang TJ;
BMC Infect Dis; 2018 Jul; 18(1):315. PubMed ID: 29986658
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of hepatitis B surface antigen and serological markers of other endemic infections in HIV-infected children, adolescents and pregnant women in Sierra Leone: A cross-sectional study.
Yendewa GA; Lakoh S; Yendewa SA; Bangura K; Lawrence H; Patiño L; Jiba DF; Vandy AO; Murray MJS; Massaquoi SP; Deen GF; Sahr F; Hoffmann CJ; Jacobson JM; Poveda E; Aguilera A; Salata RA
Int J Infect Dis; 2021 Jan; 102():45-52. PubMed ID: 33002619
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of liver cirrhosis in individuals with hepatitis B virus infection in sub-Saharan Africa: Systematic review and meta-analysis.
Surial B; Wyser D; Béguelin C; Ramírez-Mena A; Rauch A; Wandeler G
Liver Int; 2021 Apr; 41(4):710-719. PubMed ID: 33220137
[TBL] [Abstract][Full Text] [Related]
5. Challenges of hepatitis B treatment in rural Sub-Saharan Africa: Treatment initiation and outcomes from a public hospital-based clinic in Kono, Sierra Leone.
Nyama ET; Allan-Blitz LT; Bitwayiki R; Swaray M; Lebbie W; Lavalie D; Mhango M; Gupta N; Rodriguez MP
J Viral Hepat; 2023 May; 30(5):455-462. PubMed ID: 36740953
[TBL] [Abstract][Full Text] [Related]
6. The gamma-glutamyl transpeptidase-to-platelet ratio predicts liver fibrosis and cirrhosis in HBeAg-positive chronic HBV infection patients with high HBV DNA and normal or mildly elevated alanine transaminase levels in China.
Li Q; Li W; Huang Y; Chen L
J Viral Hepat; 2016 Nov; 23(11):912-919. PubMed ID: 27375134
[TBL] [Abstract][Full Text] [Related]
7. Association of Coexistent Hepatitis B Surface Antigen and Antibody With Severe Liver Fibrosis and Cirrhosis in Treatment-Naive Patients With Chronic Hepatitis B.
Wang J; Ding W; Liu J; Liu Y; Yan X; Xia J; Wu W; Jia B; Chen Y; Gao D; Hong S; Wang X; Wang L; Tong X; Yin S; Zhang Z; Li J; Huang R; Wu C
JAMA Netw Open; 2022 Jun; 5(6):e2216485. PubMed ID: 35696167
[TBL] [Abstract][Full Text] [Related]
8. Liver fibrosis in treatment-naïve HIV-infected and HIV/HBV co-infected patients: Zambia and Switzerland compared.
Wandeler G; Mulenga L; Vinikoor MJ; Kovari H; Battegay M; Calmy A; Cavassini M; Bernasconi E; Schmid P; Bolton-Moore C; Sinkala E; Chi BH; Egger M; Rauch A;
Int J Infect Dis; 2016 Oct; 51():97-102. PubMed ID: 27596685
[TBL] [Abstract][Full Text] [Related]
9. Effect of Concomitant Positive Hepatitis B Surface Antigen on the Risk of Liver Metastasis: A Retrospective Clinical Study of 4033 Consecutive Cases of Newly Diagnosed Colorectal Cancer.
Huo T; Cao J; Tian Y; Shi X; Wu L; Zhang M; Wong LL; Zhao L
Clin Infect Dis; 2018 Jun; 66(12):1948-1952. PubMed ID: 29293940
[TBL] [Abstract][Full Text] [Related]
10. Cross sectional study of chronic hepatitis B prevalence among healthcare workers in an urban setting, Sierra Leone.
Massaquoi TA; Burke RM; Yang G; Lakoh S; Sevalie S; Li B; Jia H; Huang L; Deen GF; Beynon F; Sahr F
PLoS One; 2018; 13(8):e0201820. PubMed ID: 30096162
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Chronic Hepatitis B Virus Infection in Sierra Leone, 1997-2022: A Systematic Review and Meta-Analysis.
Yendewa GA; Wang GM; James PB; Massaquoi SPE; Yendewa SA; Ghazawi M; Babawo LS; Ocama P; Russell JBW; Deen GF; Sahr F; Kabba M; Tatsuoka C; Lakoh S; Salata RA
Am J Trop Med Hyg; 2023 Jul; 109(1):105-114. PubMed ID: 37217165
[TBL] [Abstract][Full Text] [Related]
12. Acceptability and feasibility of a screen-and-treat programme for hepatitis B virus infection in The Gambia: the Prevention of Liver Fibrosis and Cancer in Africa (PROLIFICA) study.
Lemoine M; Shimakawa Y; Njie R; Taal M; Ndow G; Chemin I; Ghosh S; Njai HF; Jeng A; Sow A; Toure-Kane C; Mboup S; Suso P; Tamba S; Jatta A; Sarr L; Kambi A; Stanger W; Nayagam S; Howell J; Mpabanzi L; Nyan O; Corrah T; Whittle H; Taylor-Robinson SD; D'Alessandro U; Mendy M; Thursz MR;
Lancet Glob Health; 2016 Aug; 4(8):e559-67. PubMed ID: 27443781
[TBL] [Abstract][Full Text] [Related]
13. Chronic hepatitis B virus infection in Asian countries.
Merican I; Guan R; Amarapuka D; Alexander MJ; Chutaputti A; Chien RN; Hasnian SS; Leung N; Lesmana L; Phiet PH; Sjalfoellah Noer HM; Sollano J; Sun HS; Xu DZ
J Gastroenterol Hepatol; 2000 Dec; 15(12):1356-61. PubMed ID: 11197043
[TBL] [Abstract][Full Text] [Related]
14. Liver function test abnormalities in Nigerian patients with human immunodeficiency virus and hepatitis B virus co-infection.
Iroezindu MO; Agbaji OO; Daniyam CA; Isiguzo GC; Isichei C; Akanbi MO
Int J STD AIDS; 2013 Jun; 24(6):461-7. PubMed ID: 23970749
[TBL] [Abstract][Full Text] [Related]
15. NIH consensus development statement on management of hepatitis B.
Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
[TBL] [Abstract][Full Text] [Related]
16. Changes in APRI and FIB-4 in HBeAg-negative treatment-naive chronic hepatitis B patients with significant liver histological lesions receiving 5-year entecavir therapy.
Liu R; Guo J; Lu Y; Zhang L; Shen G; Wu S; Chang M; Hu L; Hao H; Li M; Xie Y
Clin Exp Med; 2019 Aug; 19(3):309-320. PubMed ID: 31111345
[TBL] [Abstract][Full Text] [Related]
17. Association between Hepatitis B Virus Infection and Metabolic Syndrome in Southwest China: A Cross-sectional Study.
Yan LB; Liao J; Han N; Zhou LY; Wang XE; Wang YJ; Tang H
Sci Rep; 2020 Apr; 10(1):6738. PubMed ID: 32317690
[TBL] [Abstract][Full Text] [Related]
18. Sero-prevalence of hepatitis B virus markers and associated factors among children in Hawassa City, southern Ethiopia.
Argaw B; Mihret A; Aseffa A; Tarekegne A; Hussen S; Wachamo D; Shimelis T; Howe R
BMC Infect Dis; 2020 Jul; 20(1):528. PubMed ID: 32698884
[TBL] [Abstract][Full Text] [Related]
19. Screening and linkage to care for medical students with hepatitis B virus infection in Sierra Leone.
Kachimanga C; Bangura M; Nyama E; Mhango M; Reed V; Rodriguez MP; Lado M
Heliyon; 2020 Aug; 6(8):e04673. PubMed ID: 32802989
[TBL] [Abstract][Full Text] [Related]
20. Serum hepatitis B surface antigen quantification as a useful assessment for significant fibrosis in hepatitis B e antigen-positive hepatitis B virus carriers.
Xun YH; Zang GQ; Guo JC; Yu XL; Liu H; Xiang J; Liu J; Shi JP
J Gastroenterol Hepatol; 2013 Nov; 28(11):1746-55. PubMed ID: 23800140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
